Cumberland Pharmaceuticals Inc SEC filings CPIX
Cumberland Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Mar 18, 2009. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Mar 12, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Aug 25, 2025 | — |
| CORRESP | Letter to the SEC | Aug 15, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2025 | — |
| EFFECT | Filing | Dec 26, 2023 | — |
| CORRESP | Letter to the SEC | Dec 21, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2023 | — |
| DEL AM | Filing | Dec 15, 2023 | — |
| EFFECT | Filing | Jan 8, 2021 | — |
| CORRESP | Letter to the SEC | Jan 6, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2020 | — |
| CORRESP | Letter to the SEC | Oct 16, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2020 | — |
| CORRESP | Letter to the SEC | Jul 22, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2020 | — |
| CT ORDER | Filing | Dec 20, 2018 | — |
| EFFECT | Filing | Jan 16, 2018 | — |
| CORRESP | Letter to the SEC | Jan 11, 2018 | — |
| CORRESP | Letter to the SEC | Dec 29, 2017 | — |
| CORRESP | Letter to the SEC | Dec 18, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2017 | — |
| CT ORDER | Filing | Aug 18, 2017 | — |
| CT ORDER | Filing | Apr 13, 2017 | — |
| DEFR14A | Filing | Mar 20, 2017 | — |
| CT ORDER | Filing | Dec 2, 2016 | — |
| CT ORDER | Filing | Aug 17, 2016 | — |
| CT ORDER | Filing | Apr 26, 2016 | — |
| CT ORDER | Filing | Apr 26, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2015 | — |
| CORRESP | Letter to the SEC | Sep 14, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2015 | — |
| CT ORDER | Filing | May 12, 2014 | — |
| CT ORDER | Filing | Jun 21, 2013 | — |
| CT ORDER | Filing | Jun 21, 2013 | — |
| CT ORDER | Filing | May 14, 2013 | — |
| CT ORDER | Filing | Jan 22, 2013 | — |
| EFFECT | Filing | Nov 15, 2012 | — |
| CORRESP | Letter to the SEC | Nov 14, 2012 | — |
| CT ORDER | Filing | Nov 2, 2012 | — |
| CORRESP | Letter to the SEC | Oct 26, 2012 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2012 | — |
| SC TO-I/A | Sc to | May 23, 2012 | — |
| SC TO-I/A | Amendment no. 2 | May 10, 2012 | — |
| CORRESP | Letter to the SEC | May 9, 2012 | — |
| CORRESP | Letter to the SEC | May 7, 2012 | — |
| SC TO-I/A | Filing | May 7, 2012 | — |
| UPLOAD | Letter from the SEC | May 3, 2012 | — |
| SC TO-I | Filing | Apr 24, 2012 | — |
| CT ORDER | Filing | Apr 10, 2012 | — |
| CT ORDER | Filing | Dec 14, 2011 | — |
| CT ORDER | Filing | Oct 31, 2011 | — |
| CT ORDER | Filing | Jul 21, 2011 | — |
| CT ORDER | Filing | Jul 21, 2011 | — |
| CT ORDER | Filing | Jun 1, 2011 | — |
| CT ORDER | Filing | Jun 1, 2011 | — |
| CT ORDER | Filing | Feb 23, 2011 | — |
| CT ORDER | Filing | Jan 10, 2011 | — |
| CT ORDER | Filing | Aug 26, 2010 | — |
| CT ORDER | Filing | Jun 22, 2010 | — |
| CT ORDER | Filing | May 5, 2010 | — |
| EFFECT | Filing | Aug 10, 2009 | — |
| CT ORDER | Filing | Aug 10, 2009 | — |
| CT ORDER | Filing | Aug 10, 2009 | — |
| CORRESP | Letter to the SEC | Aug 5, 2009 | — |
| CERTNAS | Auto-generated paper document | Aug 4, 2009 | — |
| CORRESP | Letter to the SEC | Jul 29, 2009 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2009 | — |
| CORRESP | Letter to the SEC | Jul 28, 2009 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2009 | — |
| CORRESP | Letter to the SEC | Jul 17, 2009 | — |
| CORRESP | Letter to the SEC | May 11, 2009 | — |
| CORRESP | Letter to the SEC | Apr 9, 2009 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2009 | — |
| CORRESP | Letter to the SEC | Mar 20, 2009 | — |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CPIX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TN
- Headquarters
- Nashville,, TN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1087294
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.